Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The O-specific polysaccharide (OSP) antigen of *Vibrio cholerae* is a key structural and immunogenic component of the bacterium’s lipopolysaccharide (LPS) layer. It forms the outermost domain of LPS, projecting from the bacterial surface, and is responsible for serogroup specificity in *V. cholerae*. The structure and composition of this antigen vary between different serogroups, most notably O1 and O139, which are associated with epidemic cholera. It is a target for diagnostics and vaccine development.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O-specific Polysaccharide Antigen (OSP).